Park Ha Biological Technology Co., Ltd. Announces Pricing of $2.0 Million Registered Direct Offering

Park Ha Biological Technology Co., Ltd. announced the pricing of its registered direct offering, expecting to raise approximately $2.0 million. The offering includes Class A ordinary shares and pre-funded warrants at a combined price of $1.50 per share and warrant. The company plans to use the net proceeds for general corporate and working capital purposes. The offering is expected to close around June 15, 2026. D. Boral Capital LLC is serving as the sole placement agent. The securities are being offered under an effective shelf registration statement on Form F-3. Park Ha Biological Technology Co., Ltd. is primarily engaged in developing its private skincare label, direct sales, and franchise alliances under the brand "Park Ha".